IRON Financial LLC Sells 727 Shares of Colgate-Palmolive (NYSE:CL)

IRON Financial LLC cut its stake in Colgate-Palmolive (NYSE:CL) by 7.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,067 shares of the company’s stock after selling 727 shares during the quarter. IRON Financial LLC’s holdings in Colgate-Palmolive were worth $941,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of CL. Valeo Financial Advisors LLC boosted its stake in Colgate-Palmolive by 5.1% in the 1st quarter. Valeo Financial Advisors LLC now owns 11,426 shares of the company’s stock valued at $1,029,000 after purchasing an additional 552 shares during the period. Lake Street Private Wealth LLC boosted its position in shares of Colgate-Palmolive by 36.1% in the first quarter. Lake Street Private Wealth LLC now owns 4,402 shares of the company’s stock valued at $396,000 after acquiring an additional 1,168 shares during the period. Norden Group LLC acquired a new position in shares of Colgate-Palmolive in the first quarter valued at about $532,000. Kovack Advisors Inc. increased its position in Colgate-Palmolive by 22.3% during the first quarter. Kovack Advisors Inc. now owns 4,745 shares of the company’s stock worth $427,000 after acquiring an additional 865 shares during the period. Finally, Diversify Advisory Services LLC acquired a new stake in Colgate-Palmolive in the 1st quarter worth about $911,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock remained flat at $94.66 on Thursday. The stock had a trading volume of 1,155,438 shares, compared to its average volume of 4,341,933. The company has a fifty day moving average of $102.69 and a 200 day moving average of $98.17. The stock has a market capitalization of $77.34 billion, a price-to-earnings ratio of 27.13, a P/E/G ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a one year low of $73.97 and a one year high of $109.30. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Activity

In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares in the company, valued at approximately $1,069,868.70. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 43,490 shares of company stock valued at $4,486,063. Insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on CL. Sanford C. Bernstein increased their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Finally, Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.